Business
Physiomics AACR Presentation
Physiomics AACR Presentation.
About this update from Physiomics Plc
[{"type":"text","content":"\n Physiomics PLC\n13 February 2008\n\n Physiomics plc\n The Magdalen Centre\n The Oxford Science Park\n Robert Robinson Avenue\n Oxford\n OX4 4GA\n UK\n\n Tel 01865 784980\n Fax 08701 671931\n\n13 February 2008\n\n\n\n Physiomics plc ('Physiomics' or 'the Company')\n\n Physiomics to present on Chronotherapy at the Annual Meeting of American\n Association of Cancer Research ('AACR')\n\nPhysiomics plc (AIM: PYC), the Oxford, UK based systems biology company, is\npleased to announce that it will be participating in the 2008 AACR Annual\nMeeting, taking place in San Diego, on 12-16 April 2008. Dr Eric Fernandez,\nwill present a development update on the Company's chronotherapy research\nprogram, as part of the EU funded TEMPO (Temporal Genomics for Tailored\nChronotherapeutics) project. The abstract will be published in the 2008\nProceeding of the AACR and will be presented in the poster session 'Cellular and\nMolecular Biology 8', scheduled for 1:00 pm on 13 April.\n\n\n\nMore information about the conference may be found at www.aacr.org\n\n\n\nFor further information:\n\n Physiomics plc +44 (0)1865 784980\n Dr Christophe Chassagnole, COO\n E-mail: [email protected]\n Grant Thornton Corporate Finance +44 (0)20 7383 5100\n Philip Secrett, Colin Aaronson\n \n\n\nAbout TEMPO project (LSHG-CT-2006-037543)\n\nIn 2006 Physiomics has been selected to participate in the TEMPO Project as one\nof four Industry partners working closely with four distinguished European\nacademic research groups. The project is coordinated by INSERM unit director\nProf Francis Levi, at Paul Brousse hospital in Villejuif (France).\n\n\n\nThis three year programme is exploring the effect of circadian rhythms (the\nbody's clock) on changes in cell proliferation and the effectiveness of cancer\ndrugs and will use this knowledge to optimise treatment. The aim is to optimise\ntreatment of individual patients taking into account the 24h rhythms generated\nby the patient's biological clock. Physiomics is using its cell simulation\ntechnologies to study the effect of cancer drugs on the cell cycle/circadian\nclock system behaviour, at the cellular level, the cell population level\n(virtual Fluorescence-Activated Cell-Sorting experiment) or tissue level\n(virtual tumour). Using pharmacokinetics simulation in connection with\npharmacodynamics profile, Physi...